This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

The Effect of the Treatment Program "Dr. Fedon Lindbergs Vektcoach" on Body Weight and Composition and Hormonal Profile

This study has been completed.
Information provided by (Responsible Party):
Eurodiet Scandinavia AS Identifier:
First received: November 4, 2010
Last updated: August 14, 2012
Last verified: August 2012

The background for the trial is a number of previous studies indicating that it is especially important to restrict the intake of carbohydrates when treating overweight and metabolic diseases in general.

The purpose of the study is to obtain research data on the effects of an established treatment of overweight/obesity and its related metabolic disorders. The treatment, "Dr. Fedon Lindbergs Vektcoach", is a combination treatment where patients use low carbohydrate and low energy "Eurodiet" products in the initial phases. After the initial phases are completed, low glycemic normal foods are added to the diet until a sustainable and healthy diet is achieved. The treatment is of 7 month duration.

Condition Intervention
Overweight Obesity Metabolic Syndrome Other: The "Dr. Fedon Lindbergs Vektcoach" Treatment

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Official Title: The Effect of a Low Carbohydrate Low Energy Ketogenic Diet Followed by Progressively Increased Intake of Low Glycemic Foods Over 7 Months on Weight and Body Composition and Hormonal Profile

Resource links provided by NLM:

Further study details as provided by Eurodiet Scandinavia AS:

Primary Outcome Measures:
  • Body weight/composition [ Time Frame: 7 months ]

Secondary Outcome Measures:
  • Hormonal profile [ Time Frame: 7 months ]

Enrollment: 44
Study Start Date: October 2010
Study Completion Date: August 2012
Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Eurodiet treatment Other: The "Dr. Fedon Lindbergs Vektcoach" Treatment
Diet and lifestyle treatment


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Body Mass Index (BMI)>35
  • BMI>27 + one risk factor for cardiovascular disease or metabolic syndrome
  • >18 years

Exclusion Criteria:

  • Medicinal treatment of thyroid disease
  • Pregnancy or planned pregnancy
  • Taking of diet pills like Xenical or Sibutramine
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01235208

Dr. Fedon Lindbergs Klinikk
Oslo, Norway
Sponsors and Collaborators
Eurodiet Scandinavia AS
Principal Investigator: Pål T Jåbekk, M.Sc
Study Director: Arne T Høstmark, Ph.D/Dr.Med Unaffiliated/ Study supervisor
  More Information

Responsible Party: Eurodiet Scandinavia AS Identifier: NCT01235208     History of Changes
Other Study ID Numbers: EDstudy
Study First Received: November 4, 2010
Last Updated: August 14, 2012

Keywords provided by Eurodiet Scandinavia AS:
Metabolic syndrome
Low glycemic index

Additional relevant MeSH terms:
Metabolic Syndrome X
Body Weight
Signs and Symptoms
Insulin Resistance
Glucose Metabolism Disorders
Metabolic Diseases processed this record on August 16, 2017